Craneware Plc (LON:CRW) reported a 52% rise in annual profit before tax to $24 million for the year ended June 30, 2025, compared with $15.7 million a year earlier, as revenue increased and finance costs fell, the company reported on Monday.
Shares of the automated software and services provider were up 1.7% at 07:10 ET (11:10 GMT).
Revenue rose 9% to $205.7 million from $189.3 million. Annual recurring revenue climbed 7% to $184 million, while net revenue retention improved to 107% from 98% in 2024.
Adjusted EBITDA increased 12% to $65.3 million, representing a margin of 32%, up from 31%.
Earnings also strengthened. Basic earnings per share rose 68% to 56.2 cents from 33.5 cents, while diluted EPS rose 66% to 55.2 cents from 33.2 cents.
Adjusted basic EPS rose 22.5% to 116.1 cents, and adjusted diluted EPS rose 21.6% to 114.2 cents.
The UK-based company reported operating cash conversion of 94% of adjusted EBITDA, compared with 90% a year earlier.
Cash and cash equivalents grew to $55.9 million from $34.6 million, while total bank debt fell to $27.7 million from $35.4 million.
The board proposed a final dividend of 18.5 pence per share, giving a total of 32 pence for the year, up 10% from 29 pence in 2024.
Chief executive Keith Neilson said the results reflected stronger growth across the business.
“The year has seen us deliver on our commitment to increase our growth rate, while maintaining strong profit margins, reducing bank debt, increasing our dividend and providing an admirable return on our customers’ investment in the Group’s software,” Neilson said.
The company flagged continued sales momentum, with customer retention above 90%. Expansion among existing clients and the transition of Trisus platform revenues to recurring income supported growth.
Craneware also launched Trisus Assist, an AI tool designed for healthcare finance and operations teams. Thirteen Trisus solutions are now listed on the Microsoft Azure Marketplace, with initial contracts secured through the platform.
During the year, Craneware rejected an unsolicited takeover proposal of £26.50 per share. The board said no formal negotiations were held and unanimously dismissed the approach.
Board changes saw the departures of Colleen Blye and Russ Rudish, while Tamra Minnier of UPMC and Susan Nelson of MedStar Health joined as non-executive directors.
Since year end, Craneware agreed to a new unsecured revolving credit facility of $100 million with an additional $100 million accordion feature. The facility replaces existing loans and was agreed on improved terms.
Craneware said trading in the early months of fiscal 2026 had started well and that growth in recurring revenues provided a foundation for further expansion.
Source :
https://www.investing.com/news/earnings/craneware-posts-strong-fy25-results-lifts-dividend-after-profit-jump-4238387
